The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

Johnson & Johnson faces the first product liability personal injury lawsuit over side effects of Levaquin that caused peripheral neuropathy for Karyn Grossman, from Maryland. According to Grossman, she developed the severe and often permanent form of nerve damage after using the popular antibiotic.

The lawsuit was filed in September in the U.S. District Court for the Northern District of California, against Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals subsidiary and the drug distributor, McKesson Corp. as defendants.

FDA 2013 Warnings

In 2013, the FDA required new warnings about the risk of nerve damage and peripheral neuropathy associated with the fluoroquinolones class of antibiotics including Cipro, Avelox and others.

According to the FDA, peripheral neuropathy could occur at any time during treatment with the popular antibiotics and may continue for months or even years after use of the medications is stopped.

What is Peripheral Neuropathy?

Peripheral neuropathy occurs because of damage to the nerves, which reduces sensation and movement. Symptoms which can be severe and debilitating include pain, burning, tingling, numbness, weakness, and sensitivity to light touches, temperature and motion in the arms and legs. The disease can be very difficult to treat and include antidepressants, vitamins and physical aides such as walking sticks and in catastrophic cases folks are wheel chair bound.

Plaintiff Levaquin Side Effect Allegations

According to Grossman, Johnson & Johnson ignored information about the link between Levaquin and peripheral neuropathy for years, failed to adequately warn patients and doctors about the risk of permanent and long-lasting nerve damage.

Grossman claims that, “The warning label for Levaquin during the period from September 2004 through August 2013 misled Plaintiff and her treating physician by incorrectly advising patients and physicians that peripheral neuropathy associated with Levaquin was ‘rare’ and in any case could be avoided by discontinuing the drug upon the onset of certain symptoms. The truth, however, is that the onset of irreversible peripheral neuropathy is often rapid and discontinuation of the drug will not ensure that the peripheral neuropathy is reversible.”

Levaquin Nerve Damage Side Effect Risk

Levaquin is one of the most widely used antibiotics in the world, and is part of the popular class of medications known as fluoroquinolones, which have previously been linked to a number of serious health issues, including a risk of tendon ruptures, retinal detachment and kidney problems. Other drugs in the same class include Cipro, Avelox, Noroxin, Floxin and Factive.

Levaquin is used to tackle bacterial pneumonia, bacterial chronic bronchitis, life-threatening bacterial infections such as meningitis, symptoms caused by multiple, concurrent bacterial infections and bacterial infections that are resistant to other antibiotics. Women are sometimes prescribed Levaquin for routine bacterial urinary tract infections.

Levaquin Blockbuster Drug

Levaquin is a blockbuster drug, and a tremendous cash cow for Johnson and Johnson. About 23.1 million patients received a prescription for an oral fluoroquinolone in 2011. Cipro dominated the market, comprising 70% of those prescriptions, followed by Levaquin or a generic equivalent, which was used by 28%.

Another 3.8 million patients received injections in 2011, with Levaquin or a generic equivalent making up 63% of those, followed by Cipro at 28%. According to IMS Health, which tracks prescription drugs sales, Levaquin was the best-selling antibiotic drug in the United States in 2010, with sales of about $1.5 billion.

Johnson & Johnson “knew or should have known”

Plaintiffs have alleged that Johnson & Johnson knew or should have known about the risk of peripheral neuropathy from Levaquin and other fluoroquinolones as early as 1992, when a case report was published in the British medical journal, The Lancet.

Other studies were published in 1996 and 2001, highlighting cases where users of fluoroquinolone antibiotics experienced symptoms of peripheral nerve damage, including numbness, pain and muscle weakness.

Researchers found that over half of patients experienced symptoms lasting more than a year, and 80% characterized the nerve problems as severe.

One Comment

  1. Gravatar for Glenn Miller
    Glenn Miller

    I was treated extensively with Levaquin and Cipro starting in 2009 and almost immediately was diagnosed with severe Permanent Bi-Lateral Upper and Lower Peripheral Neuropathy. I have all the hospital documentation of this condition, records and prescriptions. They have tried all the know treatments including tripling the dosage with no positive results. I am in constant pain and have had Tendon Tears requiring to walk with crutches.

Comments for this article are closed.